• Nenhum resultado encontrado

Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials

N/A
N/A
Protected

Academic year: 2023

Share "Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials"

Copied!
12
0
0

Texto

Referências

Documentos relacionados

Lastly, due to the limited amount of evidence, our study included a small number of clinical trials (n=7) and therefore a greater number of controlled trials are required